HSRCongress2023
Towards Innovation and Entrepreneurship - Challenges from Research to Clinics
-
Plenary Session I
Ruman Rahman (PhD)Done
-
Openning Session
Done
-
Enterprise Plenary Session II
Carlos Neto (PharmD)Done
-
Plenary Session IV
Professor Jens PahnkeDone
-
Congress Dinner
Done
-
Hot Topics III: Dementia: Conventional vs. Alternative therapies
Assunção Vaz Patto, Associate Professor at Universidade da Beira Interior and Liliana Sousa, Associate Professor at Universidade de AveiroDone
-
Flash Session I (B)
Clara B. MartinsDone
-
Flash Session II (B)
Ana ValenteDone
-
Oral Session IV A
Nádia OliveiraDone
-
Plenary Session II
Roland Bücker (Ph.D.)Done
Event HSRCongress2023
starts on
12 February 2023 at 08:00:00 UTC
Enterprise Plenary Session III
15/02/2023, 09:40
-
15/02/2023, 10:40
(UTC)
(1 hour)
GenIbet Biopharmaceuticals is a company whose mission is to manufacture safe and reliable breakthrough products to support worldwide customers on building the therapies of the future. With a team of more than 50 highly qualified professionals, GenIbet supports its customers on the development and manufacturing of unique novel modalities covering a wide range of technologies.
Sofia Venceslau obtained her Ph.D. degree from the NOVA University of Lisbon, Institute of Chemical and Biological Technology (Oeiras, Portugal) in 2011 and is currently a Project Manager in GenIbet Biopharmaceuticals and will be the third confirmed enterprise speaker for the HSR Congress 2023 on February 15th, 2023.
